Highlighting results from first FDA-reported study for treatment of presbyopia

Season 2, Episode 1,   Sep 27, 2021, 04:21 AM

Headliner
Share
Subscribe
George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.
Share
Subscribe
Next
ROP: Treating and preventing blindness in preterm babies
Top episodes
What patients need to know about cataract surgery
by EyePod
Integrating AI to manage DR in a primary care setting
by EyePod
Modifier Gene Therapy: What is it?
by EyePod